Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Pain 10Neoplasms 9Marijuana Abuse 5Cancer Pain 5Glioblastoma 2Squamous Cell Carcinoma of Head and Neck 1Signs and Symptoms 1Recurrence 1Parasomnias 1Pancreatic Neoplasms 1Neuralgia 1Nausea 1Multiple Sclerosis 1Mouth Neoplasms 1Marijuana Use 1Diabetes Mellitus 1Chronic Pain 1Cachexia 1Breast Neoplasms 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1Advanced Malignant Solid Tumor 1Advanced Cancer 11- Cancer Patients During Chemotherapy Treatment 1

Interventions

Pregabalin 5Lidocaine 4Surveys and Questionnaires 3Bupivacaine 3ziconotide 2Transcranial Magnetic Stimulation 2Oxycodone 2Gabapentin 2Capsaicin 2Amitriptyline 2onabotulinum toxin A 1nabiximols 1Yoga 1Vitamin B 6 1Vitamin B 12 1Vinorelbine 1Vincristine 1Transcutaneous Electric Nerve Stimulation 1Thalidomide 1Telmisartan 1Tapentadol 1Spinal Cord Stimulation 1Sodium Chloride 1Saline Solution 1Radiofrequency Ablation 1Plastic Surgery Procedures 1Paclitaxel 1Oxaliplatin 1Morphine 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuralgia × nabiximols × Clear all
NCT02073474 2022-12-20

An Observational Post-Marketing Safety Registry of Sativex®

Jazz Pharmaceuticals

Completed
978 enrolled

Marijuana Abuse, Diabetes Mellitus, Multiple Sclerosis, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡